Share Name Share Symbol Market Type Share ISIN Share Description
Croda International Plc LSE:CRDA London Ordinary Share GB00BJFFLV09 ORD 10.609756P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -18.00p -0.38% 4,730.00p 4,738.00p 4,742.00p 4,752.00p 4,674.00p 4,720.00p 337,321 16:35:06
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 1,386.9 317.8 181.4 26.1 6,234

Croda Share Discussion Threads

Showing 476 to 499 of 575 messages
Chat Pages: 23  22  21  20  19  18  17  16  15  14  13  12  Older
DateSubjectAuthorDiscuss
22/1/2014
16:56
Upbeat comments from analysts at HSBC gave chemicals stocks a boost in London on Wednesday after they said that the sector will deliver double-digit growth in earnings in 2014. The bank believes that all regions should contribute to growth, while it sees upside risk to prices and margins. "The valuation of the sector is not cheap but justifiable in our view as the overall market has re-rated by more," analysts said in a research note. HSBC raised its rating for Croda International from 'neutral' to 'overweight' and lifted its target price from 2,700p to 2,800p. Heavyweight Johnson Matthey also saw its target raised from 3,450p to 3,750p, though a 'neutral' recommendation was maintained.
broadwood
22/1/2014
08:41
HSBC Croda International PLC 22/01/2014 Upgrades Neutral Overweight 2 2,700.00 2,800.00 2,424.00 100 2
broadwood
09/11/2013
11:16
trend is now down but an opportunity should present itself soon, given the reduced growth I wouldnt pay above 2000p for it currently, institutions must still be reducing.
pyemckay
09/11/2013
08:59
I am looking for a buying opportunity in the coming week.
miata
01/11/2013
16:17
Buy tip www.shareprophets.advfn.com/views/2275/buy-croda
phoenix1234
31/10/2013
17:31
yes, eps growth of 35% over last 3 years but not now. take the blinkers off. past returns are no guide to the future.
pyemckay
31/10/2013
16:36
pyemckay - the chart pattern for croda is consistent and on or close to a support line on the defined trend, a trend that has been in place for at least 3 years.
erogenous jones
31/10/2013
16:20
and out of my small holding late in the day. high pe low growth is not a good combination. good luck all.
pyemckay
31/10/2013
15:37
crda now in danger of losing ftse 100 status.
pyemckay
31/10/2013
10:00
mixed bag of results. crda showing decline in certain markets. Compared to trading update from elementis this week I have a larger holding now in elementis. crda only a hold for me at present. disappointing, and market agrees.
pyemckay
31/10/2013
08:37
Great buying opportunity here
con90210
31/10/2013
07:51
- Chemical group Croda International said sales trends improved again in Q3 with growth across all regions despite subdued market conditions. Turnover was up 4.4% to £267.9m (2012: £256.5m) with underlying sales up 0.8%. The significant devaluation of the Japanese Yen and Indian Rupee reduced the benefit of currency translation compared to the first half. Innovation led sales were very strong in all segments with double digit growth seen in new and patented products. However, we saw near double digit declines in relatively low margin but high volume commodity and toll manufacturing sales. Operating margins remained solid at 23.1% (2012: 23.2%) despite slight dilution due to the acquisition of Sichuan Sipo Chemical Co ("Sipo"), with continuing operating profit up 4.0% to £62.0m (2012: £59.6m). Group pre-tax profit increased 5.4% to £58.6m (2012: £55.6m) in the quarter. In Consumer Care, sales were up 3.2% to £145.4m (2012: £140.9m) supported by both volume growth and a better quality product mix. Overall trends were mixed. Personal Care sales continued to improve with strong sales in Western Europe and North America, although we saw sales decline again in Eastern Europe, Middle East and Africa. Crop Care made further progress following its return to growth in June, although whilst we saw strong double digit turnover increases in Europe, growth was more modest elsewhere. Health Care sales were also up in the quarter compared to the same period in 2012. Operating profit increased 3.2% to £45.6m (2012: £44.2m). Return on sales in the quarter was 31.4% (2012: 31.4%). In Performance Technologies sales were up 0.4% to £95.0m (2012: £94.7m) with growth in Geotech and Polymer Additives. Home Care and Coatings & Polymers were both down with particularly weak sales in North America. Lubricants saw sales decline in Europe. The Group currency benefit is skewed towards Performance Technologies due to its relatively high exposure to European markets. Operating profit increased 4.5% to £13.9m (2012: £13.3m). Return on sales was 14.6% (2012: 14.0%). Industrial Chemicals continued to see good underlying sales growth which was boosted by the acquisition of Sipo in July 2013. Turnover increased 31.6% to £27.5m (2012: £20.9m). Sipo broke even at the operating profit level which diluted the return on sales in the sector. Operating profit increased 19.0% to £2.5m (2012: £2.1m). Return on sales was 9.1% (2012: 10.0%). Cash generation was very strong in the quarter with net debt falling £8.6m to £213.7m.This was despite a £45.6m increase in borrowings due to the acquisition of 65% of the equity of Sipo in the quarter. Martin Flower, Chairman, said: "Croda has continued to generate a steadily improving underlying sales performance through every quarter of this year despite challenging market conditions. We continue to benefit from the strong demand for innovation and remain particularly encouraged by the progress that Croda is making in Asia and South America. However, with currencies continuing to weaken and market conditions expected to remain subdued, fourth quarter profits are likely to be similar to quarter three. Looking ahead, the Board remains confident that Croda's strategy will continue to deliver progress into 2014 and beyond."
broadwood
31/10/2013
07:44
On the money as usual. Croda has continued to generate a steadily improving underlying sales performance through every quarter of this year despite challenging market conditions. We continue to benefit from the strong demand for innovation and remain particularly encouraged by the progress that Croda is making in Asia and South America. However, with currencies continuing to weaken and market conditions expected to remain subdued, fourth quarter profits are likely to be similar to quarter three. Looking ahead, the Board remains confident that Croda's strategy will continue to deliver progress into 2014 and beyond
broadwood
25/10/2013
16:31
Benefitting from ELM's results today.
broadwood
14/10/2013
10:20
hmmm I jumped the gun there and purchased a little early.
erogenous jones
12/10/2013
16:13
Name........... P/E.. Price ..30DayChg Croda Int ..... 19.1 2,477.00p -6.63% Elementis ..... 16.1 . 238.70p -7.26% Johnson Matthey 18.8 2,821.00p -5.24% Victrex ....... 18.6 1,598.00p -4.31% 09-Oct-13 Bank of America Buy 2,570.00p 2,870.00p 2,870.00p 09-Oct-13 Credit Suisse Outperform 2,570.00p 3,000.00p 3,000.00p 03-Oct-13 Berenberg Bank Buy 2,677.00p 3,100.00p 3,100.00p 02-Oct-13 Deutsche Buy 2,668.00p 2,850.00p 2,850.00p
miata
12/10/2013
12:52
Just wait until the next IMS. 31 October 2013 Q3 Interim Management Statement
broadwood
12/10/2013
11:59
higher pe than some in the sector but not a huge amount of growth to support this. would be a buyer if this fell significantly. not real value at the minute.
pyemckay
12/10/2013
09:11
Hargreaves Lansdown? They usually are excellent. I have a couple of accounts there plus accounts with Charles Stanley and Charles Stanley Direct. Worst outfit was Self Trade to the point thst not only was complaint made to the FSA, but to have my money returned, I resorted to the point of preparing a Statutary Demand which was emailed to every board member for that shabby outfit plus the French bank that ultimately owned it. I received my money in the following couple of days and, funnily enough, fees were considerably reduced for the securities transferred in specie
erogenous jones
11/10/2013
17:05
Downgrades from JP Morgan to neutral from overweight and from Liberum to hold from buy.
miata
11/10/2013
16:34
Would have done if I could have dealt on H-L. Really angry!!!! T
turbomouth
11/10/2013
16:24
Better top up I think
erogenous jones
07/10/2013
13:58
BlackRock holding gone above 5%
broadwood
04/10/2013
07:26
Miata - yep, saw that.
broadwood
Chat Pages: 23  22  21  20  19  18  17  16  15  14  13  12  Older
Your Recent History
LSE
CRDA
Croda
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191019 19:30:11